Immunotherapy Genetics 101

Live EBAY Auctions

Cancer Immunotherapy at the Crossroads: How Tumors Evad

US $187.80
End Date: Sunday Feb-05-2012 18:29:54 PST
Buy It Now for only: US $187.80
Buy it now | Add to watch list

Immunotherapy of Cancer NEW by Patricia Yotnda

US $182.05
End Date: Monday Feb-06-2012 8:43:33 PST
Buy It Now for only: US $182.05
Buy it now | Add to watch list

Immunotherapy of Infections, Masihi, Noel:

US $33.53
End Date: Monday Feb-06-2012 15:18:42 PST
Buy It Now for only: US $33.53
Buy it now | Add to watch list

Immunotherapy of Cancer NEW by Patricia Yotnda

US $159.82
End Date: Monday Feb-06-2012 18:19:49 PST
Buy It Now for only: US $159.82
Buy it now | Add to watch list

IMMUNOTHERAPY OF CANCER - PATRICIA YOTNDA (HARDCOVER) NEW

US $131.25
End Date: Tuesday Feb-07-2012 7:43:21 PST
Buy It Now for only: US $131.25
Buy it now | Add to watch list

Cancer Immunology and Immunotherapy: Vol 344 Dranoff, G

US $202.33
End Date: Tuesday Feb-07-2012 8:13:24 PST
Buy It Now for only: US $202.33
Buy it now | Add to watch list

Immune Dysfunction and Immunotherapy in Heart Dise - Wa

US $139.10
End Date: Tuesday Feb-07-2012 9:33:35 PST
Buy It Now for only: US $139.10
Buy it now | Add to watch list

Cancer Immunotherapy: Immune Suppression and Tumor Grow

US $106.90
End Date: Tuesday Feb-07-2012 11:53:37 PST
Buy It Now for only: US $106.90
Buy it now | Add to watch list

Experimental and Applied Immunotherapy NEW

US $211.49
End Date: Tuesday Feb-07-2012 13:45:59 PST
Buy It Now for only: US $211.49
Buy it now | Add to watch list

Immunotherapy with Intravenous Immunoglobulins by

US $5.14
End Date: Tuesday Feb-07-2012 13:53:32 PST
Buy It Now for only: US $5.14
Buy it now | Add to watch list

Internet Search Results

Immunotherapy - Wikipedia, the free encyclopedia
Immunotherapy is a medical term defined as the "treatment of disease by inducing, enhancing, or suppressing an immune response". Immunotherapies designed to elicit or ...

Immunotherapy - American Cancer Society :: Information and ...
Immunotherapy is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of ...

Allergen immunotherapy - Wikipedia, the free encyclopedia
Allergen immunotherapy (also termed hyposensitization therapy, immunologic desensitization, hyposensibilization, or allergen-specific immunotherapy) is a form of ...

immunotherapy: Definition from Answers.com
n. , pl. , -pies . Treatment of disease by inducing, enhancing, or suppressing an immune response. immunotherapeutic im ' mu·no·ther ' a·peu ' tic ( -pyū ' tĭk ...

Allergy Shots (Immunotherapy) Effectiveness, Side Effects, & More
Allergy shots, also called "immunotherapy," are given to increase your tolerance to the substances (allergens) that provoke allergy symptoms. They usually are ...

Allergy Shots (Immunotherapy) | AAAAI
Allergy Shots (Immunotherapy) Allergen immunotherapy, also known as allergy shots, is a form of long-term treatment that decreases symptoms for many people with ...

Immunotherapy - What You Need to Know - Asthma- All About Your Asthma
Immunotherapy is one of the many potential treatments for your asthma. Just like other medications, it has risks and benefits. Learn about the benefits of ...

Immunotherapy - KidsHealth - the Web's most visited site about ...
About Immunotherapy. Immunotherapy, also known as target therapy or biotherapy, is a promising new cancer treatment that stimulates a patient's immune system so it is ...

Immunotherapy Cancer Treatment - Cancer Supportive and ...
The concept of immunotherapy is based on the body's natural defense system, which protects us against a variety of diseases. One immediate goal of research in cancer ...

Immunotherapy - National Center for Biotechnology Information
Physicians should consider injection immunotherapy using appropriate allergens for the treatment of allergic asthma only when the allergic component is well ...

* View Newest Amazon Items!

* Latest "Immunotherapy" News *

Go Back to Top

Results Support Planned, Randomized Phase 3 ADAPT Study-
MarketWatch (press release)
4, 2012 /PRNewswire via COMTEX/ -- Argos Therapeutics Inc. today announced that updated results from an open label Phase 2 study of its Arcelis(TM) immunotherapy, AGS-003, in combination with sunitinib in patients with unfavorable risk, ...

and more »

Vaccine Eyed for Early-Stage Prostate Ca
MedPage Today
Explain that the immunotherapy agent sipuleucel-T (Provenge) appears safe for use earlier in prostate cancer. Point out that the trial also confirmed the expected immune-cell responses when given outside of the approved setting in patients with ...

and more »

Compugen Cancer Target Results Demonstrate Significant Potential for Cancer ...
MarketWatch (press release)
Dr. Anat Cohen-Dayag, CEO of Compugen, remarked, "Immunotherapy is one of the most promising new approaches for the treatment of various cancers, and within this field, mAb immunotherapy appears to be the most rapidly growing segment.

and more »

Research and Markets: Cancer Therapies - Global Strategic Business Report ...
SunHerald.com
This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. The report provides separate comprehensive analytics for the US, ...

and more »

Medgadget.com

Groundbreaking Personalized Cancer Immunotherapy Trial About to Start
Medgadget.com
by Gene Ostrovsky on Jan 25, 2012 • 3:48 pm The Center for Immunotherapy at Roswell Park Cancer Institute (RPCI) is about to begin a very exciting new cancer clinical trial that will test a personalized immunotherapy to attack cancer cells.
Immunotherapy Cancer Trials With Key Data Due In 2012Seeking Alpha
Phase I clinical trials for dendritic cell vaccine designed to both eradicate ...Next Big Future
Researchers target multiple tumors in new cancer vaccine studyFierceVaccines
Rediff -UPI.com
all 52 news articles »

Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With ...
SYS-CON Media (press release)
31, 2012 /PRNewswire/ -- Argos Therapeutics Inc., today announced that it presented a high resolution immune monitoring analysis of AGS-003-006, a Phase 2 study of its Arcelis™ immunotherapy, AGS-003, in combination with sunitinib in patients with ...

and more »

Proactive Investors USA & Canada

ImmunoCellular's CEO to present at Immunotherapy conference in San Diego
Proactive Investors USA & Canada
ImmunoCellular Therapeutics (OTC:) said Monday its chief executive Manish Singh will make a presentation about cancer stem cells at the Immunotherapeutics Partnering and Deal Making Conference. The conference is taking place in San Diego, ...
ImmunoCellular Therapeutics To Deliver Presentation on Cancer Stem Cells at ...MarketWatch (press release)

all 13 news articles »

Proactive Investors USA & Canada

OncoSec Medical to present at World Centre Immunotherapy Conference
Proactive Investors USA & Canada
OncoSec Medical (OTC:ONCS) said Tuesday that its chief business officer Michael Cross will present at the World Centre Immunotherapy Conference in San Diego. The company, which is developing advance-stage ElectroOncology therapies to treat people with ...
OncoSec to Present at World Cancer Immunotherapy ConferenceMarketWatch (press release)

all 8 news articles »

Pfizer, J&J subsidiary, charity group launch Alzheimer's Challenge 2012
Drug Store News
The drug maker said it would work with Janssen Alzheimer Immunotherapy, its partner on the Alzheimer's Immunotherapy Program, and a subsidiary of J&J and the Geoffrey Beene Gives Back Alzheimer Initiative to introduce the Alzheimer's Challenge 2012 at ...
Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's CareMarketWatch (press release)
Pfizer offers $300000 Alzheimer's ChallengeTheDay.com (blog)
Pfizer (NYSE:PFE) In Johnson & Johnson DealStocksandShares.TV
4-traders (press release)
all 29 news articles »

Cancer immunotherapy partners face big test with Phase III program
FierceBiotech
Merck KGaA and Oncothyreon ($ONTY) will learn soon whether their lung cancer vaccine has a shot at being one of the next bright lights in the cancer immunotherapy arena, with an interim analysis set for this quarter expected to determine whether the ...

and more »